Docebo Inc. (NASDAQ: DCBO) – Q4 2025 Earnings
Docebo Inc. (NASDAQ: DCBO) – Q4 2025 Earnings
Press release and earnings call link
Earnings Release Date: Feb. 27, 2026
Stock Price: $17.91
Market Cap: $514.8 million
Q4 2025 sales of $63.0 million vs $57.0 million in the prior year
Q4 2025 Non-GAAP Adjusted EPS of $0.45 vs $0.28 in the prior year
Q4 2025 GAAP Diluted EPS of $0.91 vs $0.38 in the prior year
Overview: Docebo is a SaaS (software subscription) learning platform provider that sells enterprise learning management and related modules, positioning itself as “AI-first” and expanding into skills intelligence via the 365Talents acquisition.
Revenue drivers: Primarily subscription revenue (94% of total) with a smaller professional services component (implementation/support).
Customers/end-markets: Mid-market to large enterprise; notable traction in quick-service restaurants (QSR), regulated orgs, and a growing public sector motion (federal + state/local).
Market positioning: Established enterprise LMS (learning management system) vendor trying to differentiate with AI workflows + multi-product suite (LMS + skills).
Recent trajectory: Steady, not hypergrowth: Q4 revenue +11% YoY and ARR (annual recurring revenue) +8.4% YoY; profitability improving with Adj. EBITDA margin 21.2%.
Near-term themes (management): 1) “AI-first” product narrative, 2) integrating 365Talents and cross-selling, 3) re-accelerating enterprise execution, 4) building a longer-dated government growth vector, 5) capital return via substantial issuer bid (SIB).
Competitive Advantage Insights
Press Release vs Call Transcript Comparison
Press release reads like a “proof of discipline” quarter (margin up, cash flow, buyback, named wins).
Call reads like a “transition narrative”: they are telling investors the next leg depends on (1) enterprise execution, (2) 365Talents cross-sell, and (3) longer-cycle government wins—i.e., fewer “pure numbers” and more “operating playbook.”
If you’re underwriting the stock, the question becomes: Do you believe their execution fixes convert pipeline into >10% growth without sacrificing margins? The press release provides the base case; the call provides the argument for upside.
Positive Insights
Negative Insights
Investor Underappreciation Signals
✅OEM concentration collapse — The largest OEM customer fell to 4.4% of ARR from 9.5%, but the market may still price Docebo like it has major single-customer risk; confirmation over the next few quarters could reduce the risk discount.
✅NRR “looks worse than it is” — Reported NRR is 99%, but management says excluding AWS it would be ~101% and improving; as the AWS drag fully laps, reported NRR could normalize and change sentiment fast.
✅QSR rollout certainty — The press release touts the QSR win, but the call clarifies it’s mandated company-wide (not franchise-by-franchise), which investors may not appreciate when modeling ramp speed.
✅365Talents cross-sell timing — The press release sells the “multi-product” idea, but the call pins attach momentum to H2 2026; investors may be underestimating the impact once cross-training ends and bundling becomes repeatable.
✅Government is a 2027 lever hiding in 2026 chatter — The press release highlights public sector wins now, but the call explains the ARR-to-revenue timing (Fed fiscal dynamics); investors focused only on 2026 may miss the setup for 2027 acceleration.
Tariff Risk
No material discussion of U.S. tariffs or trade policy impacts appears in the transcript excerpt provided. There are no comments about tariffs affecting revenue, supply chain, pricing, margins, market share, or mitigation actions.
Hot Stock Trends Analysis
Previous Earnings Call
Quarter-over-quarter comparison
In Q3 2025, Docebo’s story is “execution is working”—mid-market and EMEA are beating expectations, retention is improving (even as AWS churn is flagged), and FedRAMP is already producing federal wins earlier than planned; the company frames headwinds (Dayforce wind-down) as manageable and largely optical.By Q4 2025, the narrative tightens into a more investor-defensive “why growth is low and how it re-accelerates” storyline: management acknowledges enterprise underperformance, emphasizes that reported growth is masked by Dayforce and AWS, and introduces a clearer path to upside through (1) enterprise conversion, (2) 365Talents as a second product with H2 cross-sell attach, and (3) confidence-backed capital returns via the SIB—while also admitting AI monetization is still experimental and mixed.
Year-over-year comparison
Q4 2024 Story: Docebo is transforming into an AI-first platform. FedRAMP and enterprise expansion are strong growth catalysts. The company is aggressively investing in product innovation while maintaining discipline. The future is transformational and expansion-driven.
Q4 2025 Story: Growth slowed to high single digits. Enterprise execution needs improvement. Structural headwinds masked underlying strength. The path forward is disciplined execution, 365Talents cross-sell, government maturation, and margin leverage — with capital returns supporting valuation.
Final Takeaway
Docebo is in a stabilization-to-re-acceleration phase, focusing on enterprise execution, 365Talents cross-sell, and building a government growth vector while maintaining strong profitability discipline. While management cites strong demand, improving sales cycle velocity, and bookings strength masked by AWS/Dayforce headwinds, there are concerns about large enterprise deal conversion, AI monetization uncertainty, and integration execution on its largest acquisition. Execution on enterprise conversions and improved reported retention metrics by Q3/Q4 2026 will be critical for future performance. Verdict: HOLD, with upside if enterprise and cross-sell traction translate into sustained faster growth.
